Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements Recruiting Phase 2 Trials for Vincristine (DB00541)

Also known as: Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

IndicationStatusPhase
DBCOND0131475 (Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03136146Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaTreatment